B. Johnson, T. Pham, K. Young, L. Bantis, W. Sun, and A. Kasi, “Epidermal Growth Factor Receptor Inhibitor Treatment Timing does not Impact Survival in Stage 4 Colon Cancer Treatment: A Retrospective Study: EGFR Inhibitor Treatment Line Outcomes”, kjm, vol. 15, no. 2, pp. 273–277, Aug. 2022, doi: 10.17161/kjm.vol15.15975.